The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2017

Filed:

Apr. 14, 2016
Applicant:

Med-el Elektromedizinische Geraete Gmbh, Innsbruck, AT;

Inventors:

Claude Jolly, Innsbruck, AT;

Ingeborg Hochmair, Axams, AT;

Anandhan Dhanasingh, Innsbruck, AT;

Pavel Mistrik, Pardubice, CZ;

Soeren Schilp, Mieders, AT;

Roland Hessler, Innsbruck, AT;

Kenneth Mugridge, Innsbruck, AT;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/18 (2006.01); A61M 31/00 (2006.01); A61M 5/142 (2006.01); A61M 39/02 (2006.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61M 5/145 (2006.01); A61M 5/168 (2006.01); A61M 25/00 (2006.01); A61M 39/10 (2006.01);
U.S. Cl.
CPC ...
A61M 31/002 (2013.01); A61M 5/1454 (2013.01); A61M 5/14276 (2013.01); A61M 5/16813 (2013.01); A61M 39/0208 (2013.01); A61M 39/0247 (2013.01); A61N 1/0541 (2013.01); A61N 1/36032 (2013.01); A61M 25/007 (2013.01); A61M 2039/025 (2013.01); A61M 2039/0241 (2013.01); A61M 2039/1072 (2013.01); A61M 2205/04 (2013.01); A61M 2205/7518 (2013.01); A61M 2210/0668 (2013.01);
Abstract

An implantable drug delivery system includes a middle ear section with a proximal end fixed to a tympanic membrane of a patient, and a distal end that penetrates through a fluid-tight sealed opening into the inner ear. An inner ear section has a proximal end that is connected to the distal end of the middle ear guide member at the sealed opening, and a closed distal end terminating the inner ear holding member some predetermined distance within the cochlea. A hollow interior of the inner ear section is configured for containing a replaceable pharmaceutical agent, and an outer surface is configured to release the pharmaceutical agent from the hollow interior into the inner ear of the patient. The middle ear section and the inner ear section are configured to cooperate for replacing the pharmaceutical agent through the proximal end of the middle ear section to the inner ear section.


Find Patent Forward Citations

Loading…